Andrew Hamilton Acquires Albendazole.com Through Pale Horse Capital for Vetr
Acquisition connects a high-value pharmaceutical domain with Vetr’s growing Albendamax business and broader animal-health strategy GRANTS PASS, OR, September 05 2026 – Andrew Hamilton, founder and CEO of veterinary health company Vetr, has...